Cargando…

An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer

Increasing evidence has indicated that current tumor-node-metastasis (TNM) stage alone cannot predict prognosis and adjuvant chemotherapy benefits accurately for stages II and III gastric cancer (GC) patients after surgery. In order to improve the predictive ability of survival and adjuvant chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Hongfei, Chen, Yang, Yang, Zichang, Li, Zhi, Che, Xiaofang, Xiao, Jiawen, Liu, Yunpeng, Qu, Xiujuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890018/ https://www.ncbi.nlm.nih.gov/pubmed/33613554 http://dx.doi.org/10.3389/fimmu.2020.621623

Ejemplares similares

NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer
por: Yan, Hongfei, et al.
Publicado: (2019)

Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer
por: Zhang, Shuairan, et al.
Publicado: (2021)

DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53-deficient pancreatic cancer cells
por: Jing, Wei, et al.
Publicado: (2018)

Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma
por: Dong, Qian, et al.
Publicado: (2017)

Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature
por: Zhang, Chuang, et al.
Publicado: (2021)

Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer
por: Ma, Rui, et al.
Publicado: (2021)

Association of Preoperative Chemosensitivity With Postoperative Survival in Patients With Resected Gastric Adenocarcinoma
por: Deng, Lei, et al.
Publicado: (2021)

Identification of Subtype-Specific Three-Gene Signature for Prognostic Prediction in Diffuse Type Gastric Cancer
por: Bao, Bowen, et al.
Publicado: (2019)

Identification of Key Gene and Pathways for the Prediction of Peritoneal Metastasis of Gastric Cancer by Co-expression Analysis
por: Zhang, Simeng, et al.
Publicado: (2020)

Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma
por: Yang, Bowen, et al.
Publicado: (2019)

TNPO2 operates downstream of DYNC1I1 and promotes gastric cancer cell proliferation and inhibits apoptosis
por: Gong, Libao, et al.
Publicado: (2019)

N(6)-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1
por: Wang, Duo, et al.
Publicado: (2021)

Assessment of Nine Driver Gene Mutations in Surgically Resected Samples from Patients with Non-Small-Cell Lung Cancer
por: Wang, Shuo, et al.
Publicado: (2020)

Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients
por: Li, Jianxia, et al.
Publicado: (2020)

CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer
por: Wang, Jin, et al.
Publicado: (2020)

Correction for: CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer
por: Wang, Jin, et al.
Publicado: (2022)

MicroRNA-1224 Inhibits Tumor Metastasis in Intestinal-Type Gastric Cancer by Directly Targeting FAK
por: Wang, Jin, et al.
Publicado: (2019)

Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway
por: Wang, Xiaoxun, et al.
Publicado: (2020)

The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
por: LIU, YONG-PING, et al.
Publicado: (2013)

LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma
por: Wu, Jie, et al.
Publicado: (2021)

Correction to: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma
por: Wu, Jie, et al.
Publicado: (2021)

Correction: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma
por: Wu, Jie, et al.
Publicado: (2023)

Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients
por: Zhang, Fang, et al.
Publicado: (2023)

Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients
por: Hu, Bo, et al.
Publicado: (2022)

A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy()
por: Wang, Jin, et al.
Publicado: (2016)

Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-κB)-Dependent Pathway
por: Cheng, Yu, et al.
Publicado: (2020)

CXCL12/SDF-1α induces migration via SRC-mediated CXCR4-EGFR cross-talk in gastric cancer cells
por: Cheng, Yu, et al.
Publicado: (2017)

A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer
por: Wang, Jie, et al.
Publicado: (2022)

PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: A network meta-analysis
por: Guo, Xiaoyu, et al.
Publicado: (2022)

Development of lactate‐related gene signature and prediction of overall survival and chemosensitivity in patients with colorectal cancer
por: Tong, Zhi, et al.
Publicado: (2023)

Caveolin-1 enhances RANKL-induced gastric cancer cell migration
por: Wang, Yan, et al.
Publicado: (2018)

Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy
por: Yang, Qiong, et al.
Publicado: (2013)

CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
por: Zhang, Chenlu, et al.
Publicado: (2018)

Adjuvant therapy in resectable gastric cancer.
por: Bleiberg, H., et al.
Publicado: (1992)

Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer
por: Qu, Jing-lei, et al.
Publicado: (2013)

PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR
por: Lv, Jinqi, et al.
Publicado: (2020)

Succinylation Regulators Promote Clear Cell Renal Cell Carcinoma by Immune Regulation and RNA N6-Methyladenosine Methylation
por: Lu, Wenqing, et al.
Publicado: (2021)

Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2021)

Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker
por: Bai, Jin, et al.
Publicado: (2020)

Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity
por: Chi, Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cn7s88dv4csp77pumns7rlvfde